Table 3

- Allele frequency of the RPL5 genetic polymorphisms in hepatic vein thrombosis (HVT) patients compared with the control subjects.

db SNP b153 v 2	Alleles	Patients	Control	P-value*	Unadjusted OR [95% CI]
rs138979590	G	224 (87.3)	198 (87.6)		Reference
	C	26 (9.1)	16 (7.1)	0.350	1.44 [0.75-2.76]
	T	36(12.6)	12(5.3)	0.006*	2.65 [1.34-5.24]
rs558220259	A	221 (77.3)	183 (80.9)	0.362	Reference
rs558220259	G	65 (22.7)	43 (19.1)		1.25 [0.81-1.93]
rs576892621	A	233 (81.5)	189 (83.6)	0.603	Reference
rs576892621	G	53 (18.5)	37 (16.3)		1.16 [0.73-1.84]
rs182018447	G	229 (80.1)	201 (88.9)	0.009*	Reference
rs182018447	A	57 (19.9)	25 (11.1)		2.00 [1.23-3.32]
rs559377519	A	238 (83.2)	202 (89.4)	0.032*	Reference
rs559377519	T	48 (16.8)	24 (10.6)		1.73 [1.02-2.92]

↵Values are presented as number and percentage (%).
* P-values were calculated by chi-square analyses. differences were statistically significant at p<0.05.
↵OR: odds ratio, CI: confidence interval. Single-variant association analyses was performed.